BAYTRIL FLAVOUR TABLETS 50 MG

Country: Ireland

Bahasa: Inggeris

Sumber: HPRA (Health Products Regulatory Authority)

Bahan aktif:

ENROFLOXACIN

Boleh didapati daripada:

Bayer Limited

Kod ATC:

QJ01MA90

INN (Nama Antarabangsa):

ENROFLOXACIN

Dos:

50 mg/tablet

Borang farmaseutikal:

Tablets

Jenis preskripsi:

POM

Kumpulan terapeutik:

Canine

Kawasan terapeutik:

Enrofloxacin

Tanda-tanda terapeutik:

Antibacterial

Status kebenaran:

Authorised

Tarikh kebenaran:

1988-10-01

Ciri produk

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril Flavour Tablets 50 mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
Light brown to brown, slightly marbled, round, curved, scored tablets
for oral administration to dogs
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is for use in dogs in the treatment of bacterial
infections of the alimentary, respiratory and urogenital tracts,
skin, secondary wound infections and otitis externa where clinical
experience, supported where possible by sensitivity
testing of the causal organism, indicates enrofloxacin as the drug of
the choice.
4.3 CONTRAINDICATIONS
Not for use in dogs less than 1 year of age or in exceptionally large
breeds of dog with a longer growth period under 18
months of age, as articular cartilage may be affected during the
period of rapid growth.
Baytril Flavour Tablets 50 mg should not be used for prophylaxis.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Please see point 4.3.
Active Constituents
mg/tablet
Enrofloxacin
50.0
Relevant constituents of the Excipient
Artificial beef flavour Irradiated
12.0
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_8_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_6_
_6_
_2_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIM